MediVentures

MediVentures operates as the venture capital arm of the MEDICE Health Family, actively investing in promising early-stage start-ups across biotech, diagnostics, and digital therapies. The firm provides critical financing and leverages its extensive network and industry expertise to support portfolio companies through the initial phases of development. This strategic approach aims to foster innovative technological advancements relevant to the future of healthcare.

Established in 2019 by the MEDICE Group, MediVentures was formed with the insight that connecting emerging innovations with established industry experience can accelerate the realization of impactful healthcare solutions. Its foundation within the MEDICE Health Family allows it to share entrepreneurial risk with start-ups while also benefiting from the comprehensive industry knowledge residing within the parent organization. Philipp Große is associated with the venture as a key representative.

The company primarily serves start-ups focused on new therapeutic approaches and diagnostic tools, offering them opportunities for collaboration within the broader MEDICE ecosystem. MediVentures' long-term vision is to ensure the MEDICE Health Family gains access to future therapies and diagnostic advancements, seeking not only financial returns but also market-oriented knowledge that aligns with MEDICE's strategic goals and potential for future product licensing.